Inverted U-shaped Association Between the Systemic Immune-inflammation Index and Colorectal Polyps in Chinese Patients: a Cross-sectional Study

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2025 Feb 11

PMID 39931434

Authors

Jie Bao

Yajie Teng

Yingxue Yang

Qinghua Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: The systemic immune-inflammation index (SII) has been found to be associated with various inflammatory and neoplastic diseases. The aim of this study was to investigate the relationship between the SII and colorectal polyps (CPs) in Chinese patients.

Methods: This was a cross-sectional study. We retrospectively collected data from 3,028 Chinese patients who underwent physical examinations, including colonoscopy, from 2018 to 2022. We conducted a comparative analysis of patient characteristics among those with adenomatous polyps, non-adenomatous polyps, and individuals without CPs using descriptive statistics. We calculated the SII for each group and assessed the relationship between SII values and the presence of CPs.

Results: Our study included 3,028 individuals, of whom 1,432 (47.29%) had colorectal polyps. After adjusting for confounding variables, the natural logarithm of the SII (Ln-SII) was significantly associated with the prevalence of adenomatous polyps in both males and females, with an odds ratio (OR) of 0.76 [95% confidence interval (CI): 0.65-0.88,  = 0.0003]. An inverted U-shaped relationship was observed between Ln-SII and the prevalence of colorectal polyps, including both adenomatous and non-adenomatous polyps, with a cut-off point at 5.78 (5.39 for adenomatous polyps and 5.79 for non-adenomatous polyps). Below this cut-off point, a significant association with colorectal polyps was identified, with an OR of 1.73 (95% CI: 1.25-2.40,  = 0.0009). Specifically, for adenomatous polyps, the OR was 2.91 (95% CI: 1.03-8.20,  = 0.0437), and for non-adenomatous polyps, the OR was 1.86 (95% CI: 1.31-2.65,  = 0.0006). Beyond the cut-off point, the association between Ln-SII and colorectal polyps remained significant, with an OR of 0.56 (95% CI: 0.46-0.68,  < 0.0001). In the adenomatous polyps group, the OR was 0.57 (95% CI: 0.43-0.74,  < 0.0001), and in the non-adenomatous polyps group, the OR was 0.57 (95% CI: 0.46-0.70,  < 0.0001).

Conclusion: The inverted U-shaped association between Ln-SII and the risk of colorectal polyps highlights the potential relevance of monitoring variations in SII and suggests that SII may be a promising predictor for colorectal polyp development.

References

Roperch J, Incitti R, Forbin S, Bard F, Mansour H, Mesli F . Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. BMC Cancer. 2013; 13:566. PMC: 4219483. DOI: 10.1186/1471-2407-13-566. View

Wang Q, Zhu D . The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer. J Gastrointest Oncol. 2019; 10(5):965-978. PMC: 6776812. DOI: 10.21037/jgo.2019.05.03. View

Li S, Lu Z, Wu S, Chu T, Li B, Qi F . The dynamic role of platelets in cancer progression and their therapeutic implications. Nat Rev Cancer. 2023; 24(1):72-87. DOI: 10.1038/s41568-023-00639-6. View

Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X . Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer. J Inflamm Res. 2022; 14:7131-7142. PMC: 8710076. DOI: 10.2147/JIR.S345790. View

Kamel F, Eltarhoni K, Nisar P, Soloviev M . Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers (Basel). 2022; 14(8). PMC: 9029324. DOI: 10.3390/cancers14081889. View

Tsioumpekou M, Krijgsman D, Leusen J, Olofsen P . The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease. Cells. 2023; 12(15). PMC: 10417597. DOI: 10.3390/cells12151981. View

Gunter M, Canzian F, Landi S, Chanock S, Sinha R, Rothman N . Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1126-31. DOI: 10.1158/1055-9965.EPI-06-0042. View

Hu B, Yang X, Xu Y, Sun Y, Sun C, Guo W . Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014; 20(23):6212-22. DOI: 10.1158/1078-0432.CCR-14-0442. View

Nost T, Alcala K, Urbarova I, Smith Byrne K, Guida F, Sandanger T . Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021; 36(8):841-848. PMC: 8416852. DOI: 10.1007/s10654-021-00752-6. View

10.

Jeong M, Kim H, Kim T, Kim M, Kim B, Ryu S . Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy. Obstet Gynecol Sci. 2019; 62(1):35-45. PMC: 6333767. DOI: 10.5468/ogs.2019.62.1.35. View

11.

Strum W . Colorectal Adenomas. N Engl J Med. 2016; 374(11):1065-75. DOI: 10.1056/NEJMra1513581. View

12.

Helsingen L, Kalager M . Colorectal Cancer Screening - Approach, Evidence, and Future Directions. NEJM Evid. 2024; 1(1):EVIDra2100035. DOI: 10.1056/EVIDra2100035. View

13.

Sui Q, Zhang X, Chen C, Tang J, Yu J, Li W . Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat Commun. 2022; 13(1):7316. PMC: 9705377. DOI: 10.1038/s41467-022-35096-6. View

14.

Feng Z, Lin H, Yang X, Cao S, Gu X, Zhang Z . Diagnostic Value of Inflammation-Related Indicators in Distinguishing Early Colon Cancer and Adenomatous Polyps. Cancer Control. 2023; 30:10732748231180745. PMC: 10331208. DOI: 10.1177/10732748231180745. View

15.

Mandle H, Jenab M, Gunter M, Tjonneland A, Olsen A, Dahm C . Inflammation and Gut Barrier Function-Related Genes and Colorectal Cancer Risk in Western European Populations. Mutagenesis. 2024; . DOI: 10.1093/mutage/geae008. View

16.

Yang Y, Wu C, Hsu P, Chen S, Huang S, Leong Chan W . Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020; 50(5):e13230. DOI: 10.1111/eci.13230. View

17.

Giese M, Hind L, Huttenlocher A . Neutrophil plasticity in the tumor microenvironment. Blood. 2019; 133(20):2159-2167. PMC: 6524564. DOI: 10.1182/blood-2018-11-844548. View

18.

Huai Q, Luo C, Song P, Bie F, Bai G, Li Y . Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy. Cancer Sci. 2023; 114(12):4484-4498. PMC: 10728017. DOI: 10.1111/cas.15964. View

19.

Koessler T, Bichard P, Lepilliez V, Puppa G, Ris F, Roth A . [Epidemiology, treatment and follow-up of colorectal polyps]. Rev Med Suisse. 2016; 12(519):982-8. View

20.

Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S . Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998; 339(18):1277-84. DOI: 10.1056/NEJM199810293391803. View